Comorbidity between cardiovascular disease and affective illness;Komorbidität zwischen kardiovaskulären erkrankungen und depressionen

Deutsche Medizinische Wochenschrift

Volumn 129, Issue 13, 2004, Pages 697-700

  Agelink, M W ^a,d   Baumann, B ^b   Sanner, D ^a   Kavuk, I ^a   Mueck Weymann, M ^c  

^a P   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; GUANINE NUCLEOTIDE BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE;

BEHAVIOR; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; DEPRESSION; ENDOCRINE SYSTEM; HEREDITY; HUMAN; MAJOR DEPRESSION; MELANCHOLIA; METABOLISM; MOOD DISORDER; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

CARDIOVASCULAR DISEASES; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; PROGNOSIS; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 1842588853     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-821373     Document Type: Review

References (50)

1. Agelink MW, Boz C, Ullrich H, Andrich J. Relationship between major depression and heart rate variability: clinical consequences and implications for antidepressive treatment. Psychiatry Res 2002; 113: 139-149
2. Agelink MW, Majewski T, Wurthmann C et al. Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone. J Affect Dis 2001; 62: 187-198
3. Anda R, Williamson D, Jones D et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 1993; 4: 285-294
4. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93: 1976-1980
5. Ben-David J, Zipes DP. Autonomic neural modulation of cardiac rhythm: Part 1. Basic concepts. Modern Concepts of Cardiovascular Disease 1988; 57: 41-46
6. Blumenthal JA, Williams RS, Wallace AG, Williams RB, Needles TL. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med 1982; 44: 519-527
7. Bondy B, Baghai TC, Zill P et al. Combined action of the ACE D- and the G-protein beta-3-T-allele in major depression: a possible link to cardiovascular disease? Mol Psychiatry 2002; 7: 1120-1126
8. Carney RM, Rich MW, teVelde A, Saini J, Clark K, Jaffe AS. Major depressive disorder in coronary artery disease. Am J Cardiol 1987; 60: 1273-1275
9. Comings DE, McMurray JP, Gonzales N, Ferry L, Peters WR. Association of the serotonin transporter gene with serum cholesterol levels and heart disease. Mol Genet Metab 1999; 67: 248-253
10. Coryell W, Turvey C, Leon A et al. Persistance of depressive symptoms and cardio-vascular death among patients with affective disorder. Psychosom Med 1999; 61: 755-761
11. Davidson K, Jonas BS, Dixon E, Markowitz JH. Do depression symptoms predict early hypertension - incidence in young adults in the CARDIA study. Arch Intern Med 2000; 160: 1495-1500
12. Everson SA, Goldberg DE, Kaplan GA, Cohen RD, Pukkala E, Tuomilehto J, Salonen JT. Hopelessness and risk of mortality and incidence of myocardiale infarction and cancer. Psychosom Med 1996; 58: 113-121
13. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study. Arch Intern Med 2000; 160: 1261-1268
14. Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ. Depression is a risk factor for coronary artery disease in men. Arch Intern Med 1998; 158: 1422-1426
15. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999-1005
16. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993; 270: 1819-1861
17. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatr 1998; 155: 4-11
18. Goldberg EL, Comstock GW, Hornstra RK. Depressed mood and subsequent physical illness. Am J Psychiatr 1979; 136: 530-534
19. Hayward C. Psychiatric illness and cardiovascular disease risk. Epidemiol Rev 1995; 17: 129-138
20. Herrmann C, Brand-Driehorts S, Buss U, Rüger U. Effects of anxiety and depression on 5-year mortality in 5057 patients referred for exercise testing. J Psychosom Res 2000; 48: 455-462
21. Heßlinger B, Härter M, Barth J et al. Komorbidität von depressiven Störungen und kardiovaskulären Erkrankungen. Nervenarzt 2002; 73: 205-218
22. Jiang W, Babyak M, Krantz DS et al. Mental stress-induced myocardial ischemia and cardiac events. JAMA 1996; 275: 1651-1656
23. Kannel WB, Kannel C, Paffenbarger RS, Cupples LA. Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J 1987; 113: 1489-1494
24. Kittayaphong R, Cascio WE, Light KC et al. Heart rate variability in patients with coronary artery disease: Differences in patients with higher and lower depression scores. Psychosom Med 1997; 59: 231-235
25. Lake CR, Pickar D, Ziegler MG, Lipper S, Slater S, Murphy DL. High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiatry 1982; 139: 1315-1318
26. Lederbogen F, Gilles M, Maras A et al. Increased platelet aggregability in major depression. Psychiatry Res 2001; 102: 255-261
27. Lesperance F, Frasure-Smith N, Juneau M, Theroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000; 160: 1354-1360
28. Light KC, Kothandapani RV, Allen MT. Enhanced cardiovascular and catecholamine responses in women with depressive symptoms. Int J Psychophysiol 1998; 28: 157-166
29. Linden M, Kurtz G, Baltes MM et al. Depression in the very elderly. Nervenarzt 1998; 69: 27-37
30. Lown B, Verrier RL, Rabinowitz SH. Neural and psychologic mechanisms and the problem of sudden cardiac death. Am J Cardiol 1977; 39: 890-902
31. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294: 1165-1170
32. Maes M, Smith R, Christophe A et al. Lower serum high-density lipoprotein choleste-rol (HDL) in major depression and in depressed men with serious suicidal attempts: re-lationship with immune-inflammatory markers. Acta Psychiatr Scand 1997; 95: 212-221
33. Malzberg B. Mortality among patients with in involution melancholia. Am J Psychiatr 1937; 93: 1231-1238
34. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Eng J Med 1991; 325: 618-624
35. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovas-cular disease. Epidemiology, biology and treatment. Arch Gen Psychiatr 1998; 55: 580-592
36. Penninx BWJH, Beckman ATF, Honig A et al. Depression and cardiac mortality. Arch Gen Psychiatr 1991; 58: 221-227
37. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo J, Eaton WW. Depression, psycho-tropic medication and risk of myocardial infarction. Circulation 1996; 94: 3123-3129
38. Rechlin T, Weis M, Spitzer A, Kaschka WP. Are affective disorders associated with alterations of heart rate variability? J Affect Dis 1994; 32: 271-275
39. Roose SP, Yeragani V. Antidepressants and mortality in depressed patients with concomitant illness. Eur Neuropsychopharmacol 2002; 12: S162(Suppl 3
40. Schleifer SJ, Macari-Hinson MM, Coyle DA et al. The nature and course of depression follwing myocardial infarction. Arch Intern Med 1989; 149: 1785-1789
41. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post myocardial infarction risk stratification. Circulation 1992; 85: 177-191(Suppl 1
42. Severus WE, Littman AB, Stoll AL. Omega-3 fatty acids, homocysteine, and increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry 2001; 9: 280-293
43. Stein PK, Carney RM, Freedland KE et al. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res 2000; 48: 493-500
44. Berkman LF, Blumenthal J, Burg M (et al.) Study Group Of Enhancing Recovery In Coronary Heart Disease Patients. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coro-nary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289: 3106-3116
45. Verrier RL, Calvert A, Lown B. Effect of posterior hypothalamic stimulation on ventri-cular fibrillation threshold. Am J Physiol 1975; 228: 923-927
46. Vogt T, Pope C, Mullooly J, Hollis J. Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. Am J Public Health 1994; 84: 227-231
47. Wenzel RR, Siffert W, Bruck H, Philipp T, Schafers RF. Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation. Pharmacogenetics 2002; 12: 489-495
48. Wetterling T, Junghanns K. Gerontopsychiatrischer Konsiliardienst. Psychiatr Prax 2002; 29: 311-314
49. Whyte EM, Pollock BG, Wagner WR et al. Influence of serotonin transporter promotor region polymorphism on patelet activation in geriatric depression. Am J Psychiatry 2001; 158: 2074-2076
50. Zaza A, Schwartz PJ. Role of the autonomic nervous system in the genesis of early ischemic arrhythmias. J Cardiovasc Pharmacol 1985; 7: S8-S12(suppl